Loading data
PTGXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 159.29 m USD | 138.13 m USD | 120.16 m USD | 126.22 m USD | 126.01 m USD |
| Operating profit | -158.13 m USD | 252.84 m USD | -93.65 m USD | -131.37 m USD | -125.85 m USD |
| Profit before tax | -129.31 m USD | 279.41 m USD | -78.96 m USD | -127.39 m USD | -125.55 m USD |
| Income tax expense | 838 k USD | 4.22 m USD | — | — | — |
| Net income (reported basis) | -130.15 m USD | 275.19 m USD | -78.96 m USD | -127.39 m USD | -125.55 m USD |
| Basic earnings per share | -2.05 USD/share | 4.47 USD/share | -1.39 USD/share | -2.6 USD/share | -2.71 USD/share |
| Diluted earnings per share | -2.05 USD/share | 4.23 USD/share | -1.39 USD/share | -2.6 USD/share | -2.71 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.